FDA found Listeria monocytogenes in Greenhead Lobster's ready-to-eat lobster plant and cites seafood HACCP failures.
What happened
FDA inspected the Bucksport, Maine ready-to-eat seafood plant on September 21, 22, 23, 27, and 30, and October 6, 2021, and collected 99 environmental swabs. One swab, from a floor drain cover next to the picking/cracking station where lobsters are prepared before cooking, was positive for Listeria monocytogenes. FDA also reviewed the firm's own records, which showed 13 repeat Listeria positives between May and August 2021 in the ready-to-eat room, 11 of them on food-contact surfaces such as the cooling tank, picking line table and weigh table.
What FDA found
The cooking step's monitoring plan checked internal lobster temperature too rarely to show that disease-causing bacteria were killed by the cook.
21 CFR 123.6(c)(4)Production records routinely missed the cooking limits set in the firm's own 2019 validation study, such as starting lobster temperature, steam tunnel chamber temperature, and belt speed/cooking time.
21 CFR 123.6(c)(4)Condensate was building up on the ceiling above exposed ready-to-eat cooked lobster meat, and sanitation conditions were not monitored often enough to catch it.
21 CFR 123.11(b); 21 CFR 117.20(b)(4)Water from an evaporator catch-bucket was overflowing onto the cooler floor, a repeat observation from the previous inspection, showing plumbing and drainage were not adequately maintained.
21 CFR 123.11(b); 21 CFR 117.37(b)(4)The HACCP plan had no critical control point for treating post-cook cooling water, such as measuring chlorine residual, to prevent recontamination of cooked product.
The HACCP plan does not address the risk of Clostridium botulinum growth and toxin in high pressure processed lobster packaged in oxygen-permeable film, since high pressure does not kill botulinum spores.
What FDA wants
FDA asks the firm to reply in writing within 15 working days describing the specific steps taken to correct each violation, with supporting documentation, and to explain any delay and the expected completion date if corrections are not finished. FDA says it will check whether the corrective actions were actually implemented at the next inspection.
Who should pay attention
- retailers and distributors that sell ready-to-eat seafood
- brands that buy finished seafood from contract processors
- food safety teams that run Listeria environmental monitoring programs
This is a summary. Read the original letter on fda.gov.